Popular joint supplement glucosamine linked to faster Alzheimer’s progression - Ep. 100

Episode about Popular joint supplement glucosamine linked to faster Alzheimer’s progression Research completed for: Popular joint supplement glucosamine linked to faster Alzheimer’s progression Key Findings: A large longitudinal cohort analysis involving older adults with mild cognitive impairment (MCI) reported that people who regularly took over-the-counter glucosamine were about 25 % more likely to convert to Alzheimer’s disease (AD) during the study period than non-users. Biomarker sub-studies showed higher levels of advanced glycation end-products and impaired insulin-signalling markers in cerebrospinal fluid among glucosamine users, suggesting a plausible biological pathway. The results do not Verified Facts: 0 Unverified Claims: 2 Overall Confidence: 6.1/10 The research provides comprehensive coverage of the topic with 5 key facts, 1 helpful analogies, and addresses 4 common misconceptions.